ELECTROPHYSIOLOGY DEVICES MARKET ANALYSIS

Electrophysiology Devices Market, By Product Type (Electrophysiology Monitoring Devices, Electrophysiology Treatment Devices), By Indication (Atrial Fibrillation, Atrioventricular Nodal Re-entry Tachycardia, Supraventricular Tachycardia, Bradycardia, Others), By End User (Hospitals, Diagnostic Centers, Clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In November 2023, Norav Medical, a global leader in ECG solutions, launched the innovative NR-314P Holter device, marking a major advancement in long-term cardiac monitoring. The compact yet robust NR-314P enables up to 14 days of continuous ambulatory ECG recording and boasts wireless connectivity and an easy-to-use interface.
In May 2023, Medtronic, a medical device company, announced that the U.S. Food and Drug Administration (FDA) had approved Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers. Micra AV2 and Micra VR2, the world's smallest pacemakers, provide longer battery life and easier programming than prior Micra pacemakers
In July 2022, Siemens Healthcare GmbH, a global medical technology company, launched Mobilett Impact, its newest mobile X-ray system. The system combines all the benefits of a mobile X-ray system for imaging at the patient’s bedside with full digital integration
In June 2020, Boston Scientific Corporation, a medical technology, announced the U.S. launch of the DIRECTSENSE Technology, a tool for monitoring the effect of radiofrequency (RF) energy delivery during cardiac ablation procedures